Advertise on podcast: PBS News Hour - Health

Jensen Huang, the CEO of chipmaker Nvidia, admitted to an affair with a woman accused of being a Chinese spy. The economic stakes extend well beyond Nvidia itself. With a market value still exceeding $4 trillion, the company has become a major driver of the stock market and a central force in the AI boom. To discuss the financial impact, Geoff Bennett spoke with Mohamed El-Erian. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Health care costs are climbing, putting new pressure on millions of Americans and raising questions about the coverage they can afford. The challenges extend to Medicare Advantage. In some parts of the country, insurers are pulling out of markets or eliminating plans that many rely on. We hear from seniors struggling to navigate those changes, and Geoff Bennett discusses more with Dan Weissmann. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

When actor Christina Applegate revealed that she had been misdiagnosed with multiple sclerosis, it triggered not only an outpouring of empathy for her, but raised important questions about how often people are told they have the condition when they don't. William Brangham discussed why MS can be so difficult to diagnose with Dr. Michael Kornberg of Johns Hopkins University. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

This November, voters in Virginia, Nevada, Missouri and Idaho will decide on the future of reproductive rights. In deeply red Idaho, a citizen-led initiative faces an uphill battle to restore some abortion rights. Special correspondent Sarah Varney reports on whether the fallout from the overturning of Roe v. Wade and frustration over the current law will be enough to sway conservative Idahoans. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

An estimated one in five children will experience some form of sexual abuse before the age of 18. In this episode of Settle In, Amna Nawaz speaks with clinical psychologist Elizabeth Letourneau and journalist Luke Malone, authors of "One in Five," a book that explores child sexual abuse as a public health crisis, about how education and early prevention can help protect children before harm occurs. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

The CDC has confirmed more than 4,000 cases of measles this year as the country grapples with the largest outbreak of the highly infectious virus in 35 years. Nearly a fifth of cases comprise children under the age of five, and 95% are among unvaccinated people. Amna Nawaz spoke with Dr. Evan Shirey, a pediatric infectious disease doctor based in Pennsylvania. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

The Vatican says Pope Leo has lung cancer and that doctors removed the lower lobe of his right lung in a surgery that lasted roughly 90 minutes. In a statement, the Vatican called the operation "successful" and said there were "no complications." For more on the Pope's prognosis, Geoff Bennett spoke with Dr. Omer Awan, a physician and senior public health contributor at Forbes. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Millions along the Gulf Coast are on high alert as Hurricane Isaias gains power and moves closer to land. Isaias is now a Category 2 storm, the first hurricane in the Atlantic basin this year. Forecasters are warning of heavy rain, damaging winds, flooding, storm surge and the possibility of tornadoes. Amna Nawaz discussed the latest with National Hurricane Center Director Michael Brennan. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

About 12% of Americans are now taking the blockbuster set of weight-loss medications known as GLP-1s. While their popularity continues to skyrocket, new concerns have emerged around the societal impacts these drugs are having, especially around body image. Stephanie Sy and producers Mike Fritz and Sam Lane have the story for our series, GLP-1s: Reshaping America. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Anger and backlash are building at Cornell University this week over the way the school handled an alleged gang rape in 2024. The case has renewed questions about how sexual assault allegations are investigated on college campuses and by law enforcement. Geoff Bennett discussed more with Deborah Tuerkheimer, a former prosecutor and author of "Credible: Why We Doubt Accusers and Protect Abusers." PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

In our news wrap Wednesday, Christa Pike's lawyers say she is "angry and confused" after regaining consciousness following her botched execution, a congressional candidate in Arizona says she was raped while trying to repair campaign signs and Tropical Storm Isaias is expected to strengthen into the first hurricane of the 2026 Atlantic season. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

A growing body of evidence suggests that GLP-1 drugs are not only helping millions with their diabetes and weight loss, but they're also proving effective at curbing people's desire for drugs and alcohol. William Brangham reports on the researchers who are testing whether these medications can help tackle the country's addiction crisis. It's part of our series, GLP-1s: Reshaping America. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

The U.S. is closely monitoring a potential case of pneumonic plague in Russia after a laboratory worker who studied the disease fell ill and died. Russian authorities insist there is no cause for alarm, but officials have imposed quarantines and other measures at several medical facilities in Siberia. Geoff Bennett discussed more with Annie Jacobsen, author of "Biological War: A Scenario." PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists continue to research new potential uses. But with that rapid expansion, there's a growing list of questions and skeptics. William Brangham reports for our new series, GLP-1s: Reshaping America. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy